natgillin/translations-raw huggingface dataset:
- if you or your sexual partner are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine (listed in section 6); - if you or your sexual partner have a history of allergy or sensitivity to other local anaesthetics with a similar structure (known as amide-type local anaesthetics). 
Ne uporabljajte zdravila Senstend: - če ste vi ali vaša spolna partnerka alergični na lidokain ali prilokain ali katero koli sestavino tega zdravila (navedeno v poglavju 6); - če imate vi ali vaša spolna partnerka alergijo na ali ste občutljivi na druge lokalne anestetike s podobno strukturo (znanimi kot lokalni anestetiki amidnega tipa) v anamnezi.
Uncommon Anorectal discomfort, oral parasthesia 
Neprijetni občutek v anorektalnem področju, peroralna parestezija
Uncommon Genital erythema, ejaculation failure, paraesthesia of male genital, penile pain, penis disorder, pruritus genital 
Eritem spolovil, odsotnost ejakulacije, parestezija moških spolovil, bolečine v penisu, težave s penisom, srbenje spolovil
Senstend is indicated for the treatment of lifelong premature ejaculation in adult men. 
Zdravilo Senstend je indicirano za zdravljenje vseživljenjske prezgodnje ejakulacije pri odraslih moških.
The following side effects have been reported with Senstend in male patients: 
Pri uporabi zdravila Senstend so poročali o naslednjih neželenih učinkih pri moških bolnikih:
Due to the risk of partner transfer, patients hoping to achieve conception should either avoid using Senstend, or, if it is essential to achieve penetration, should wash the glans penis as thoroughly as possible 5 minutes after applying the spray but prior to intercourse (see section 4.6). 
Zaradi tveganja prenosa na partnerko naj se bolniki, ki želijo spočeti otroka, izogibajo uporabi zdravila Senstend, če je njegova uporaba nujna za dosego penetracije, pa naj si 5 minut po nanosu pršila, vendar pred spolnim odnosom, čim temeljiteje sperejo glavico penisa (glejte poglavje 4.6).
The risk of additional systemic toxicity should be considered when large doses of Senstend are applied to patients already using other local anaesthetics or structurally related medicinal products, e.g. class I anti-arrhythmics such as mexiletine. 
Pri nanosu večjih količin zdravila Senstend pri bolnikih, ki že uporabljajo druge lokalne anestetike ali strukturno povezana zdravila, npr. antiaritmike razreda I kot meksiletin, je treba upoštevati tveganje za dodatno sistemsko toksičnost.
• pain or discomfort in and around the penis 
• bolečina ali neprijeten občutek v penisu in okrog njega;
Holding the can upright (valve up), apply 1 dose (3 sprays) of Senstend to the entire head of the penis, by covering one third with each spray. 
Vsebnik držite navzgor (ventil obrnjen navzgor) in na celotno glavico penisa nanesite 1 odmerek (3 razpršitve) zdravila Senstend, tako da z vsako razpršitvijo prekrijete eno tretjino.
• Para-aminosalicylic acid (PAS) - used to treat tuberculosis 
• paraaminosalicilna kislina (PAS) - uporablja se za zdravljenje tuberkuloze.
Adverse drug reactions in male glans-penis-treated subjects System Organ Class 
Neželeni učinki zdravila pri moških preiskovancih, ki so prejemali zdravljenje glavice penisa Organski sistem
Patients hoping to achieve conception should either avoid using Senstend, or, if it is essential to achieve penetration, should wash the glans penis as thoroughly as possible prior to intercourse. 
Bolniki, ki želijo spočeti otroka, naj se izogibajo uporabi zdravila Senstend, če je njegova uporaba nujna za dosego penetracije, pa naj si pred spolnim odnosom čim temeljiteje sperejo glavico penisa.
Cutaneous spray, solution Colourless to light yellow solution 
FARMACEVTSKA OBLIKA dermalno pršilo, raztopina Brezbarvna do svetlo rumena raztopina
The following side effects have been reported with Senstend in female partners: 
Pri uporabi zdravila Senstend so poročali o naslednjih neželenih učinkih pri partnerkah:
Senstend is a colourless to light yellow cutaneous spray, solution in an aluminium spray container with metering valve. 
Izgled zdravila Senstend in vsebina pakiranja Zdravilo Senstend je brezbarvna do svetlo rumena raztopina za dermalno pršilo v aluminijastem vsebniku s pršilom z odmernim ventilom.
Patients with severe hepatic disease, because of their inability to metabolise local anaesthetics normally, are at greater risk of developing toxic plasma concentrations of lidocaine and prilocaine (see section 4.2). 
Pri bolnikih s hudo jetrno boleznijo obstaja večje tveganje za razvoj toksičnih koncentracij lidokaina in prilokaina v plazmi zaradi nezmožnosti normalne presnove lokalnega anestetika (glejte poglavje
Senstend is indicated for the treatment of primary premature ejaculation in adult men. 
Zdravilo Senstend je indicirano za zdravljenje primarne prezgodnje ejakulacije pri odraslih moških.
Senstend provides topical anaesthesia to the glans penis. 
Zdravilo Senstend zagotavlja lokalno anestezijo glavice penisa.
As Senstend is applied topically to the glans penis the risk of overdose is low. 
Ker se zdravilo Senstend nanaša lokalno na glavico penisa, je tveganje za preveliko odmerjanje nizko.
Therefore, patients hoping to achieve conception should either avoid using Senstend, or, if this medicine is essential to achieve penetration, should wash the penis as thoroughly as possible five minutes after Senstend has been applied, but prior to intercourse. 
Zato naj se bolniki, ki želijo spočeti otroka, izogibajo uporabi zdravila Senstend, če je uporaba tega zdravila nujna za dosego penetracije, pa naj si pet minut po nanosu zdravila Senstend, vendar pred spolnim odnosom, čim temeljiteje sperejo glavico penisa.
Deterioriation was observed when Senstend was used with polyurethane-based female and male condoms. 
Pri uporabi zdravila Senstend z ženskimi ali moškimi kondomi na osnovi poliuretana so opazili poslabšanje.
vulvovaginal pruritus 
Ledvična okvara
A higher rate of erectile dysfunction and male genital hypoaesthesia may be experienced when using Senstend with male condoms. 
Pri uporabi zdravila Senstend z moškimi kondomi je mogoče pričakovati višjo stopnjo erektilne disfunkcije in hipestezije moškega spolovila.
• abnormal orgasm 
• motnje orgazma;
Senstend 150 mg/ml + 50 mg/ml cutaneous spray, solution lidocaine/prilocaine 
Senstend 150 mg/50 mg v 1 ml dermalno pršilo, raztopina lidokain/prilokain
Senstend is only indicated for application to the glans penis. 
Zdravilo Senstend je indicirano samo za nanos na glavico penisa.
• reduced feeling in and around the penis 
• zmanjšano čutenje v penisu in okrog njega;
Before each subsequent dose, briefly shake the spray container and then re-prime the pump by spraying 1 time into the air. 
Pred vsakim naslednjim odmerkom na kratko pretresite vsebnik s pršilom in ga aktivirajte tako, da 1-krat razpršite v zrak.
No teratogenic effects were observed in studies of embryonic/foetal development in rats and rabbits receiving doses during organogenesis. 
V študijah razvoja zarodka/ploda pri podganah in kuncih, ki so odmerke prejemali med organogenezo, niso opazili nobenih teratogenih učinkov.
- The active substances are lidocaine and prilocaine. 
Kaj vsebuje zdravilo Senstend - Učinkovini sta lidokain in prilokain.
Once the can is held upright (valve up), 1 dose of Senstend should be applied to the entire glans penis, by actuating the valve 3 times. 
Vsebnik držite navpično (ventil obrnjen navzgor) in s tremi potiski ventila na celotno glavico penisa nanesite 1 odmerek zdravila Senstend.
Senstend 150 mg/ml + 50 mg/ml cutaneous spray, solution 
IME ZDRAVILA Senstend 150 mg/50 mg v 1 ml dermalno pršilo, raztopina
Medicinal products subject to medical prescription 
DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z ZDRAVILOM
How to store Senstend 
Shranjevanje zdravila Senstend
Contents of the pack and other information What Senstend contains 
Shranjevanje zdravila Senstend Vsebina pakiranja in dodatne informacije
• redness on and around the penis 
• srbenje v penisu in okrog njega;
• feeling of burning in and around the penis 
• pekoč občutek v penisu in okrog njega.
Common Vulvovaginal burning sensation, hypoaesthesia Uncommon Vulvovaginal discomfort, vaginal pain, 
Neprijetni občutek v vulvovaginalnem področju, bolečina v nožnici, srbenje vulvovaginalnega področja
Cutaneous spray, solution 6.5 ml 
FARMACEVTSKA OBLIKA IN VSEBINA dermalno pršilo, raztopina 6,5 ml
Nervous system disorders 
Motnje orgazma
The recommended dose is 2 inhalations twice a day. 
Priporočeni odmerek sta dve inhalaciji dvakrat na dan.
Further information on Bevespi Aerosphere can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/Bevespi-Aerosphere. 
Nadaljnje informacije za zdravilo Bevespi Aerosphere so na voljo na spletni strani agencije: ema.europa.eu/medicines/human/EPAR/Bevespi-Aerosphere.
The medicine has also shown some effect on symptoms such as breathlessness although this appears modest. 
Zdravilo je pokazalo tudi nekaj vpliva na simptome, kot je zasoplost, a se zdi skromen.
The European Medicines Agency therefore decided that Bevespi Aerosphere's benefits are greater than its risks and it can be authorised for use in the EU. 
Evropska agencija za zdravila je zato zaključila, da so koristi zdravila Bevespi Aerosphere večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
In these studies, patients treated with Bevespi Aerosphere for 24 weeks had FEV1 increases of around 135 to 150 ml. 
V teh študijah se je pri bolnikih, zdravljenih z zdravilom Bevespi Aerosphere 24 tednov, FEV1 z okoli 135 ml povečal na 150 ml.
The combination has been shown to be effective at improving patients' lung function, with both components contributing to this effect. 
Njuna kombinacija se je izkazala za učinkovito pri izboljševanju delovanja pljuč, saj obe prispevata k temu učinku.
Bevespi Aerosphere (glycopyrronium bromide / formoterol) EMA/752588/2018 
Bevespi Aerosphere (glikopironijev bromid/formoterol) EMA/752588/2018
What measures are being taken to ensure the safe and effective use of Bevespi Aerosphere? 
Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Bevespi Aerosphere?
Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Bevespi Aerosphere have been included in the summary of product characteristics and the package leaflet. 
Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Bevespi Aerosphere upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
Patients who received placebo (a dummy treatment), on the other hand, had increases of up to 8 ml or reductions of up to 20 ml. 
Pri bolnikih, ki so prejemali placebo (zdravilo brez učinkovine), se je povečal za največ 8 ml ali zmanjšal za največ 20 ml.
The most common side effects with Bevespi Aerosphere (which may affect up to 1 in 10 people) include headache, nausea (feeling sick), muscle spasms and dizziness. 
Najpogostejši neželeni učinki zdravila Bevespi Aerosphere (ki se lahko pojavijo pri največ 1 od 10 bolnikov) vključujejo glavobol, navzejo (siljenje na bruhanje), mišične krče in omotičnost.
Three main studies in over 5,000 patients with COPD have shown that Bevespi Aerosphere is effective at improving patients' FEV1 (the maximum volume of air they can breathe out in one second). 
V treh glavnih študijah pri več kot 5 000 bolnikih s KOPB so pokazali, da je zdravilo Bevespi Aerosphere učinkovito pri izboljševanju bolnikovega FEV1 (največja prostornina zraka, ki jo lahko izdihne v eni sekundi).
This means that it blocks muscarinic receptors (targets) in muscle cells in the lungs. 
To pomeni, da zavira muskarinske receptorje (prijemališča) v mišičnih celicah v pljučih.
For more information about using Bevespi Aerosphere, see the package leaflet or contact your doctor or pharmacist. 
Za več informacij glede uporabe zdravila Bevespi Aerosphere glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
Patients should be shown how to use the inhaler correctly by a doctor or other healthcare professional. 
Bolnikom mora zdravnik ali drug zdravstveni delavec pokazati, kako pravilno uporabljati inhalator.
Bevespi Aerosphere (glycopyrronium bromide / formoterol) 
Bevespi Aerosphere (glikopironijev bromid/formoterol)
As for all medicines, data on the use of Bevespi Aerosphere are continuously monitored. 
Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Bevespi Aerosphere stalno spremljajo.
Side effects reported with Bevespi Aerosphere are carefully evaluated and any necessary action taken to protect patients. 
Neželeni učinki, o katerih so poročali pri zdravilu Bevespi Aerosphere, se skrbno ovrednotijo in po potrebi sprejmejo ukrepi za zaščito bolnikov.
Formoterol is a long-acting beta-2 agonist. 
Formoterol je dolgodelujoči agonist adrenergičnih receptorjev beta2.
Bevespi Aerosphere is used for maintenance (regular) treatment. 
Zdravilo Bevespi Aerosphere se uporablja za vzdrževalno (redno) zdravljenje.
Other information about Bevespi Aerosphere 
Druge informacije o zdravilu Bevespi Aerosphere
Side effects are considered mild to moderate in severity and are similar to other COPD medicines. 
Neželeni učinki so blagi do zmerni in podobni drugim zdravilom za KOPB.
Finally, the studies showed that Bevespi Aerosphere can lead to modest improvements in symptoms such as breathlessness. 
Nazadnje so študije pokazale, da lahko Bevespi Aerosphere privede do skromnega izboljšanja pri simptomih, kot je zasoplost.
Glycopyrronium bromide is a muscarinic receptor antagonist. 
Glikopironijev bromid je antagonist muskarinskih receptorjev.
The studies also showed that Bevespi Aerosphere improved FEV1 more than the single components in the medicine. 
Študije so pokazale tudi, da je zdravilo Bevespi Aerosphere izboljšalo FEV1 bolj kot posamezne sestavine v zdravilu.
An overview of Bevespi Aerosphere and why it is authorised in the EU 
Pregled zdravila Bevespi Aerosphere in zakaj je odobreno v EU
Because these receptors help control the contraction of muscles, when glycopyrronium is inhaled, it causes the muscles of the airways to relax, helping to keep the airways open. 
Ker ti receptorji pomagajo pri nadzoru krčenja mišic, se po vdihu glikopironija mišice dihalnih poti sprostijo, kar pomaga ohranjati dihalne poti prehodne.
Bevespi Aerosphere is available as a liquid in a portable inhaler device. 
Zdravilo Bevespi Aerosphere je na voljo kot tekočina v prenosnem inhalatorju.
Why is Bevespi Aerosphere authorised in the EU? 
Zakaj je zdravilo Bevespi Aerosphere odobreno v EU?
For the full list of side effects and restrictions of Bevespi Aerosphere, see the package leaflet. 
Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Bevespi Aerosphere glejte navodilo za uporabo.
It works by attaching to receptors known as beta-2 receptors found in the muscles of the airways. 
Deluje tako, da se veže na receptorje, imenovane adrenergični receptorji beta2, ki se nahajajo v mišicah dihalnih poti.
It contains the active substances glycopyrronium bromide and formoterol. 
Vsebuje učinkovini glikopironijev bromid in formoterol.
Bevespi Aerosphere is a medicine used in adults to relieve the symptoms of chronic obstructive pulmonary disease (COPD). 
Zdravilo Bevespi Aerosphere se uporablja za lajšanje simptomov kronične obstruktivne pljučne bolezni (KOPB) pri odraslih.
What are the risks associated with Bevespi Aerosphere? 
Kakšna tveganja so povezana z zdravilom Bevespi Aerosphere?
What is Bevespi Aerosphere and what is it used for? 
Kaj je zdravilo Bevespi Aerosphere in za kaj se uporablja?
The two active substances in Bevespi Aerosphere work in different ways to widen the airways and improve breathing in COPD. 
Zdravilo Bevespi Aerosphere vsebuje dve učinkovini, ki različno delujeta na širjenje dihalnih poti in izboljšanje dihanja pri KOPB.
What benefits of Bevespi Aerosphere have been shown in studies? 
Kakšne koristi je zdravilo Bevespi Aerosphere izkazalo v študijah?
When it attaches to these receptors, it causes the muscles to relax, which keeps the airways open. 
Z vezavo na navedene receptorje sprošča mišice, kar razširi dihalne poti.
The components in Bevespi Aerosphere are well established treatments of COPD. 
Učinkovini v zdravilu Bevespi Aerosphere sta dobro uveljavljeni pri zdravljenju KOPB.
How is Bevespi Aerosphere used? 
Kako se zdravilo Bevespi Aerosphere uporablja?
How does Bevespi Aerosphere work? 
Kako zdravilo Bevespi Aerosphere deluje?
MA (EU) number (Invented) name 
Številka postopka EMA Številka (EU) dovoljenja za promet
This summary was last updated in January 2009. 
Povzetek je bil nazadnje posodobljen januarja 2009.
They are generally taken three to four times a day and they should be taken for not more than 1-2 weeks. 
Navadno se jemljejo tri- do štirikrat dnevno, ne smejo pa se jemati več kot 1do 2 tedna.
It is also part of Chinese traditional medicine. 
Predstavlja tudi del tradicionalne kitajske medicine.
This information should always be read carefully before using a product. 
Te informacije je treba pred uporabo zdravila pazljivo prebrati.
This traditional use must cover a period of at least 30 years with 15 years of this use within the Community. 
Tradicionalna uporaba je opredeljena kot uporaba, ki traja najmanj 30 let, od tega 15 let na območju Skupnosti.
Many traditional herbal medicines have not been fully investigated with current scientific methods. 
Veliko tradicionalnih zdravil rastlinskega izvora še ni v celoti raziskanih z obstoječimi znanstvenimi metodami.
These combination medicines will be assessed separately by the HMPC. 
Taka kombinirana zdravila bo HMPC ocenil posebej.
IMPORTANT NOTE: The image is provided to give additional information on the source of the herbal substance/preparation. 
POMEMBNO OPOZORILO: Slika je priložena z namenom priskrbeti dodatne informacije o viru rastlinske snovi/pripravka.
Sweet fennel is a plant that grows wild in most parts of temperate Europe, but is generally considered indigenous to the shores of the Mediterranean from where it spreads eastwards to India. 
Sladki navadni komarček je rastlina, ki raste v naravi večine evropskih območij z zmernim podnebjem, za avtohtono pa velja na sredozemski obali, od koder se je razširila proti vzhodu v Indijo.
The long-standing use over more than 30 years and limited experimental studies make the traditional use in the above-mentioned indications plausible. 
Dolgoletna uporaba, ki traja že več kot 30 let, in omejene eksperimentalne študije kažejo na to, da je tradicionalna uporaba za zgoraj navedene indikacije verodostojna.
EMA/HMPC/411665/2008 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FOENICULUM VULGARE MILLER SUBSP. 
EMA/HMPC/411665/2008 ODBOR ZA ZDRAVILA RASTLINSKEGA IZVORA (HMPC) FOENICULUM VULGARE MILLER SUBSP.
The EU pharmaceutical legislation provides an opportunity for traditional herbal medicines to be officially registered, based on their traditional use, if they can be used safely without the support from a medical doctor for diagnosis, treatment and follow-up. 
Farmacevtska zakonodaja EU je priložnost za uradno registracijo tradicionalnih zdravil rastlinskega izvora na podlagi njihove tradicionalne uporabe, če jih lahko uporabljamo varno brez zdravnikove diagnoze, zdravljenja in spremljanja.
Sweet fennel fruit medicines are not recommended for use in children under 4 years of age because there is not enough information on their safe use in this group. 
Zdravila iz plodov sladkega navadnega komarčka niso priporočljiva za uporabo pri otrocih, mlajših od 4 let, ker ni dovolj podatkov o varni uporabi zdravila v tej starostni skupini.
Because sweet fennel fruit has been in use for a long time, the data reviewed by the HMPC included the results of studies from the scientific literature including studies using experimental models. 
Ker so plodovi sladkega navadnega komarčka že dolgo v uporabi, so podatki, ki jih je pregledal HMPC, vsebovali rezultate študij iz znanstvene literature, vključno s študijami na poskusnih modelih.
If you want more information on the HMPC conclusions, read the Community list entry on this herbal medicine. 
Če želite več podatkov o zaključkih HMPC, si oglejte vpis v seznam Skupnosti za to zdravilo rastlinskega izvora.
vulgare var. dulce (Miller) Thellung is provided in the HMPC Assessment Report, overview of comments received during the public consultation period and other related documents which can be found here. 
vulgare var. dulce (Miller) Thellung so na voljo v poročilu HMPC o oceni zdravila, pregledu pripomb, prejetih med javnim posvetovalnim obdobjem, in drugih povezanih dokumentih, ki jih lahko najdete tukaj.
The HMPC came to these conclusions after assessment of the bibliographic data available on sweet fennel fruit preparations. 
HMPC je do teh zaključkov prišel na podlagi ocene razpoložljivih bibliografskih podatkov o pripravkih iz plodov sladkega navadnega komarčka.
Many components have been identified in preparations containing sweet fennel fruit and it is not possible to define precisely the action of each component. 
V pripravkih, ki vsebujejo plodove sladkega navadnega komarčka, je bilo odkritih veliko sestavin, zato ni mogoče natančno določiti delovanja vsake posamezne sestavine.
The botanical Latin name of the plant is Foeniculum vulgare Miller subsp. 
Botanično latinsko ime rastline je Foeniculum vulgare Miller subsp.
The justification for the use of these preparations is found in their traditional use as herbal medicines. 
Uporaba teh pripravkov je utemeljena z njihovo tradicionalno uporabo kot zdravil rastlinskega izvora.
This image is not intended to encourage collection from the wild. 
Njen namen ni spodbuditi nabiranja rastline v naravi.
The most common side effects with sweet fennel fruit medicines are related to allergic reactions, affecting the skin or the respiratory system. 
Najpogostejši neželeni učinki zdravil iz plodov sladkega navadnega komarčka so povezani z alergičnimi reakcijami, ki prizadenejo kožo ali dihalni sistem.
The Commission decision establishing the Community list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products can be found here. 
Odločba Komisije o vzpostavitvi seznama rastlinskih snovi, pripravkov in kombinacij iz njih za uporabo v tradicionalnih zdravilih rastlinskega izvora je na voljo tukaj.
There are few studies looking at the safety of sweet fennel fruit preparations, but the many years of experience of their use in man indicate that they are sufficiently safe. 
Študij o varnosti pripravkov iz plodov sladkega navadnega komarčka je malo, vendar dolgoletne izkušnje z njihovo uporabo pri človeku kažejo, da so dovolj varni.
VULGARE VAR. DULCE (MILLER) THELLUNG, FRUCTUS FENNEL FRUIT, SWEET HMPC Assessment Report Summary for the Public 
VULGARE VAR. DULCE (MILLER) THELLUNG, FRUCTUS PLOD SLADKEGA NAVADNEGA KOMARČKA Povzetek poročila odbora HMPC o oceni zdravila
Further information on the HMPC assessment on Foeniculum vulgare Miller subsp. 
Dodatne informacije o oceni HMPC o Foeniculum vulgare Miller subsp.
Community list entries are authorised by the European Commission further to the scientific opinion of the HMPC and describe the herbal medicines, including their content, how they are used, what they are used for, how they work and how they can be used safely. 
Vpise v seznam Skupnosti odobri Evropska komisija na podlagi znanstvenega mnenja HMPC, vsebujejo pa opis zdravil rastlinskega izvora, vključno s podatki o njihovi sestavi, načinu in namenu uporabe, načinu delovanja in zagotovitvi varne uporabe zdravila.
Sweet fennel fruit medicines are available in various forms to be taken by mouth, such as herbal tea, tablets, capsules. 
Zdravila iz plodov navadnega sladkega komarčka so na voljo v različnih oblikah, ki jih zaužijemo peroralno, npr. v obliki zeliščnega čaja, tablet ali kapsul.
It was has been observed that a number of compounds detected in fennel fruit inhibit the growth of pathogenic bacteria and fungi. 
Opazili so, da številne sestavine ploda navadnega komarčka zavirajo rast patogenih bakterij in gliv.
Sweet fennel fruit medicines can be used from the age of 4 years. 
Zdravila iz plodov sladkega navadnega komarčka se lahko uporabljajo od 4. leta starosti dalje.